jabil circuit inc (JBL:New York)
David M. Stout
Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee, Jabil Circuit Inc.
|Age||Total Calculated Compensation||This person is connected to 53 board members in 5 different organizations across 7 different industries.|
See Board Relationships
Mr. David M. Stout is a Pharmaceutical Industry Consultant. Mr. Stout served as the President of Pharmaceutical Operations at GlaxoSmithKline PLC (GSK) from January 2003 to December 2007 and also served as its Member of the Corporate Executive Team. He led all GSK's global commercial activities, global manufacturing and all vaccine-related activities, including research and development, as well as other executive functions. Prior to that, Mr. Stout served as President ...
10560 Dr. Martin Luther KingPhone: 727-577-9749
St. Petersburg, Florida 33716
Board Members Memberships*
Independent Director, Member of Finance Committee, Member of Executive Committee and Member of Governance & Compensation Committee
Director, Member of Audit Committee and Member of Compensation Committee
Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Former Independent Non-Executive Director, Member of Audit, Compliance & Risk Committee and Member of Remuneration Committee
Director, Chairman of Nominating & Governance Committee and Member of Compensation Committee
Mcdaniel College, Inc
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Rajiv Kanishka Liyanaarchchie De Silva||Chief Executive Officer, President and Director|
Endo International plc
|Kåre Schultz||Chief Executive Officer and President|
H. Lundbeck A/S
|Jean-Christophe Tellier||Chief Executive Officer and Executive Director|
|F. Michael Ball||Chief Executive Officer, Director and Member of Science & Technology Committee|
|Said Samih Taleb Darwazah||Chairman and Chief Executive Officer|
Hikma Pharmaceuticals PLC
|$2.1M||Compensation as of Fiscal Year 2014.|